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Abstract
Objective: Prenatal infection is implicated in the etiology of schizophrenia. The objective of this paper is to
study the role of complement protein C1q in the psychosis of adult offspring after maternal immune
activation (MIA). In addition, effect of 7,8-dihydroxyflavone (7,8-DHF: A tropomyosin receptor kinase B
[TrkB] agonist) was also examined.
Methods: Western blot analysis of C1q in the brain regions from adult offspring after prenatal poly(I:C) (5.0
mg/kg/day from E12 to E17) exposure was performed. 7,8-DHF or vehicle was given from 4 to 8-weeks old.
Results: Expression of C1q in the prefrontal cortex (PFC) of adult offspring from poly(I:C)-Treated
pregnant mice was significantly higher than that of control group. Early treatment with 7,8-DHF during
juvenile and adolescent stages could prevent an increase of C1q in the PFC of adult offspring after MIA.
Conclusion: Therefore, it is likely that increased C1q expression in the frontal cortex may play a role in the
behavioral abnormalities of adult offspring after MIA. Furthermore, supplementation with a TrkB agonist
such as 7,8-DHF during the prodromal stage may have prophylactic effects on the behavioral abnormalities
after MIA.
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Objective: Prenatal infection is implicated in the etiology of schizophrenia. The objective of this paper is to study the role of 
complement protein C1q in the psychosis of adult offspring after maternal immune activation (MIA). In addition, effect of 7,8-dihy-
droxyflavone (7,8-DHF: a tropomyosin receptor kinase B [TrkB] agonist) was also examined.
Methods: Western blot analysis of C1q in the brain regions from adult offspring after prenatal poly(I:C) (5.0 mg/kg/day from 
E12 to E17) exposure was performed. 7,8-DHF or vehicle was given from 4 to 8-weeks old.
Results: Expression of C1q in the prefrontal cortex (PFC) of adult offspring from poly(I:C)-treated pregnant mice was significantly 
higher than that of control group. Early treatment with 7,8-DHF during juvenile and adolescent stages could prevent an increase 
of C1q in the PFC of adult offspring after MIA.
Conclusion: Therefore, it is likely that increased C1q expression in the frontal cortex may play a role in the behavioral abnormal-
ities of adult offspring after MIA. Furthermore, supplementation with a TrkB agonist such as 7,8-DHF during the prodromal stage 
may have prophylactic effects on the behavioral abnormalities after MIA.
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INTRODUCTION
Prenatal infection could be implicated in the etiology of 
schizophrenia.1,2) The offspring of prenatal rodents exposed 
to polyriboinosinic-polyribocytidylic acid (poly(I:C)) mim-
ics schizophrenia-like behavioral abnormalities in adult-
hood. Therefore, maternal immune activation (MIA) in ro-
dents has been widely used as an animal model of neuro-
developmental disorders such as schizophrenia.3,4) 
Complement protein C1q (complement component 1, q 
subcomponent), the recognition molecule of the classical 
pathway, performs a diverse range of complement and 
non-complement function. Recent evidence suggests that 
C1q plays an important role in pregnancy where its defi-
ciency and dysregulation can have adverse effects, lead-
ing to preeclampsia, missed abortion, miscarriage or spo-
ntaneous loss, and various infections.5,6) Furthermore, the 
C1q seropositivity was significantly associated with 
schizophrenia group compared to control group.7) 
Interestingly, levels of C1q IgG were significantly higher 
in mothers whose offspring developed psychoses as adults 
compared to control mothers.8) In case mothers only, C1q 
was significantly correlated with antibodies to both food 
and infections antigens including gluten, herpes simplex 
virus type 2, and adenovirus.8) These all findings suggest 
that exposure to maternal C1q activity during pregnancy 
may be a risk factor for the development of schizophrenia 
and psychosis in offspring. Therefore, it is of interest to 
study whether C1q expression is altered in the brain re-
gions of adult offspring after MIA.
Recently, we reported decreased brain-derived neuro-
trolphic factor (BDNF) and its receptor tropomyosin re-
ceptor kinase B (TrkB) signaling in the prefrontal cortex 
(PFC) of juvenile and adult offspring after MIA.9) 
Interestingly, we found that supplementation of TrkB ago-
nist 7,8-dihydroxyflavone (7,8-DHF)10,11) during juvenile 
and adolescent stages prevented behavioral abnormalities 
and loss of parvalbumin (PV)-immunoreactivity in the 
PFC of adult offspring after MIA.9) In the present study, 
we investigated whether C1q expression were altered in 
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Fig. 1. Effect of 7,8-dihydroxyflavone (7,8-DHF) supplementation 
on C1q protein in the brain regions of adult offspring of prenatal 
mice exposed to poly(I:C). (A) C1q protein. **p＜0.01, ***p＜0.001 
compared with poly(I:C)+vehicle (VEH) group. The value is 
expressed as the mean±standard error of the mean (n=5 or 6). 
(B) Representative bands for Western blot analysis of C1q and 
-actin in the brain regions of adult offspring after maternal 
immune activation. 
NS, not significant; PFC, prefrontal cortex; NAc, nucleus accum-
bens; DG, dentate gyrus.
the brain regions from the adult offspring after prenatal 
poly(I:C) exposure. In addition, we examined the effect of 
7,8-DHF supplementation during juvenile and adolescent 




Pregnant ddY mice (SLC Japan, Hamamatsu, Japan) 
were injected intraperitoneally with poly(I:C) (5.0 
mg/kg/day from E12 to E17) dissolved in 1% phosphate 
buffer saline (PBS) or vehicle (10 ml/kg) as previously 
reported.9,12) The offspring mice were treated with vehicle 
or 7,8-DHF (1 mg/ml; Tokyo Chemical Industry Co. Ltd., 
Tokyo, Japan) in drinking water for consecutive from 4 to 
8-weeks old. 7,8-DHF was dissolved in PBS containing 
17% dimethyl sulfoxide to generate a stock solution at 100 
mg/ml concentration. The stock solution (1 ml) was added 
to 100 ml of Hydropac (Hydro-Pac, Inc., Fairview, PA, 
USA) water that contained 1% sucrose (pH=7.4). 
Subsequently, normal water was given into all mice from 
8 to 10-weeks old. The protocol was approved by the 
Chiba University Institutional Animal Care and Use 
Committee (No. 28-274). 
Brain Collection and Western Blot Analysis
The mice (n=5 or 6) were used for C1q Western blot 
analysis. The brain samples of PFC, CA1, CA3 and den-
tate gyrus (DG) of the hippocampus, and nucleus ac-
cumbens (NAc) were collected as described previously.9) 
Basically, tissue samples were homogenized in Laemmli 
lysis buffer. Aliquots (10 g) of protein were measured us-
ing the DC protein assay kit (Bio-Rad, Hercules, CA, 
USA), and incubated for 5 minutes at 95oC, with an equal 
volume of 125 mM Tris/HCl, pH 6.8, 20% glycerol, 0.1% 
bromophenol blue, 10% -mercaptoethanol, 4% sodium 
dodecyl sulfate, and subjected to sodium dodecyl sulfate 
polyacrylamide gel electrophoresis, using 10% mini-gels 
(Mini-PROTEANⓇ TGXTM Precast Gel; Bio-Rad). Proteins 
were transferred onto polyvinylidenedifluoride membranes 
using a Trans Blot Mini Cell (Bio-Rad). For immuno-
detection, the blots were blocked with 2% bovine serum 
albumin in TBST (Tris buffer saline+0.1% Tween-20) for 
1 hour at room temperature, and kept with primary anti-
bodies overnight at 4oC. The following primary antibodies 
were used: anti-C1q antibody (1:500, sc-25856; Santa 
Cruz Biotechnology, Inc., Santa Cruz, CA, USA) and 
-actin (1:10,000, Sigma-Aldrich, St. Louis, MO, USA). 
The next day, blots were washed three times in TBST and 
incubated with horseradish peroxidase conjugated an-
ti-rabbit antibody or anti-mouse antibody for 1 hour at 
room temperature. After final three washes with TBST, 
bands were detected using enhanced chemiluminescence 
plus the Western Blotting Detection system (GE 
Healthcare Bioscience, Tokyo, Japan). Images were cap-
tured with a Fuji LAS3000-mini imaging system 
(Fujifilm, Tokyo, Japan) and immunoreactive bands were 
quantified. 
Statistical Analysis
The data are expressed as the mean±standard error of 
the mean (SEM). The data were analysed by two-way 
ANOVA, followed by post hoc Fisher’s least significant 
difference test. Statistical significance was set at p＜0.05.
RESULTS
We performed Western blot analysis of C1q in the PFC, 
NAc, and CA1, CA3, DG after prenatal poly(I:C) 
exposure. Two-way ANOVA analysis of data in the PFC 
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revealed statistical significant differences (poly(I:C): 
F1,20=11.16, p=0.003; 7,8-DHF: F1,20=5.411, p=0.031; in-
teraction: F1,20=5.803, p=0.026) (Fig. 1). Interestingly, 
supplementation with 7,8-DHF during juvenile and ado-
lescent periods stages could prevent an increase in the C1q 
expression in the PFC of adult offspring after prenatal 
poly(I:C) exposure (Fig. 1). Two-way ANOVA analysis 
of data in the other regions revealed no differences (Fig. 
1). These results suggest that adult offspring from preg-
nant mice exposed to poly(I:C) showed increased C1q ex-
pression in the PFC, and that supplementation with 
7,8-DHF from 4- to 8-weeks old could prevent an increase 
in the C1q in the PFC at adulthood after MIA.
DISCUSSION
Recently, we reported that supplementation with 
7,8-DHF during the juvenile and adolescent stages of off-
spring of prenatal mice exposed to poly(I:C) led to the pre-
vention of behavioral changes (e.g., cognitive deficits and 
PPI deficits), decreased BDNF-TrkB signaling in PFC 
and CA1 of hippocampus, and loss of PV in the prelimbic 
(PL) of medial PFC and CA1 of hippocampus at adult-
hood after MIA.9) Here, we found an increased C1q ex-
pression in the PFC of adult offspring from poly(I:C)- 
treated pregnant mice. Interestingly, there was an in-
creased C1q-circulating immune complexes level and 
complement receptor type 1 (CR1) expression on blood 
cells, elevated number of CR1 positive erythrocytes and re-
duced number of CR1 positive lymphocytes and mono-
cycytes in patients with schizophrenia compared to 
controls.13) Considering immune system abnormalities in 
schizophrenia,14) it is likely that increased C1q expression 
in the PFC may be involved in the behavioral abnormalities 
of adult offspring after MIA.
In this study, we also found that early treatment with 
7,8-DHF (a TrkB agonist) during juvenile and adolescent 
stages could prevent an increase of C1q in the PFC of adult 
offspring after prenatal poly(I:C) exposure, suggesting a 
role of BDNF-TrkB signaling. Therefore, it is likely that 
supplementation with a TrkB agonist such as 7,8-DHF 
during the prodromal stage may have prophylactic effects 
on offspring after prenatal immune activation. This is a 
first paper showing the role of BDNF-TrkB signaling in 
the expression of C1q in the PFC. Precise mechanisms un-
derlying the role of BDNF-TrkB signaling in the C1q ex-
pression in the PFC are currently unknown. Further study 
on the role of BDNF-TrkB signaling in C1q expression 
will be needed. 
In conclusion, this study suggests that increased C1q 
expression in the PFC may play a role in the behavioral ab-
normalities of adult offspring after MIA. Furthermore, 
supplementation of a TrkB agonist in young subjects at ul-
tra-high risk for psychosis may prevent the onset of 
psychosis. 
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